.png)
Patients with persistently controlled atopic dermatitis who had their doses reduced were able to maintain their low disease activity.
Lauren Joszt
Advertisement
Articles by Lauren Joszt
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Dermatology Times
1
Next-Generation IL-4Rα Targeting and Potential Dermatologic Implications
2
Graham Heap, MBBS, PhD, Discusses Positive Phase 3 Results for Zasocitinib
3
Auricular Acupuncture for Facial Rejuvenation: Results from a Large Real-World Clinical Series
4
Off-Label Case Series: Topical Roflumilast for Mild HS
5